Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma October 2017

Intraday Repeatability of Bruch's Membrane Opening-Based Neuroretinal Rim Measurements

PDF

Philip Enders; Andreas Bremen; Friederike Schaub; Manuel M. Hermann; Michael Diestelhorst; Thomas Dietlein; Claus Cursiefen; Ludwig M. Heindl
TAGS: bruch's basal membrane, glaucoma, optic disk, magnetic resonance angiography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(12):5195-5200. https://doi.org/10.1167/iovs.17-22812

ARVO Annual Meeting Abstract March 2012

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Latanoprost for Glaucoma

Manuel M. Hermann; Alain M. Bron; Catherine P. Creuzot-Garcher; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5108.

ARVO Annual Meeting Abstract March 2012

The Effect Of General Anesthesia On Rebound Tonometry Measurements In Normal Eyes Of Preschool Children

Andrea M. Schild; Manuel M. Hermann; Julia Fricke; Antje Neugebauer; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6778.

ARVO Annual Meeting Abstract April 2011

Effect of a new Audible and Visual Reminder Device on Adherence with Topical Timolol for Glaucoma

Manuel M. Hermann; Lebriz Ersoy; Michael Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):212.

ARVO Annual Meeting Abstract April 2011

Correlation Of Iop And Individual Adherence With The Fixed Travoprost / Timolol Therapy. A Multi-centre Study In Ambulant Glaucoma Patients

Michael Diestelhorst; Travalert Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):230.

ARVO Annual Meeting Abstract April 2010

A New Reminder System Improves Adherence With Topical Ocular Therapy Significantly

L. Ersoy; M. M. Hermann; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):181.

ARVO Annual Meeting Abstract April 2010

Comparison of Rapamycin and Mitomycin for Reduction of Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

M. M. Hermann; B. Schröter; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3199.

ARVO Annual Meeting Abstract April 2010

The Ocular Bioavailability of Latanoprost Lyophilizate 0.75 µg Compared With Xalatan® 1.5 µg

M. Diestelhorst; S. Fauser; K. Gruner; R. Sueverkruep

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5307.

ARVO Annual Meeting Abstract April 2010

Laser Flare-Cell Meter Being a Prognostic Non-Invasive Tool for Detecting Proliferative Vitreoretinopathy (PVR)

S. Schroeder; A. Caramoy; P. S. Muether; M. Diestelhorst; B. Kirchhof; S. Fauser

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6080.

ARVO Annual Meeting Abstract April 2009

Latanoprost Ophthalmic Lyophilizate Carrier Systems (OLCS)

K. Gruner; R. Suverkrup; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5555.

ARVO Annual Meeting Abstract April 2009

Spherolyophilizates as Ophthalmic Drug Delivery Systems

R. Suverkrup; K. Gruner; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5557.

ARVO Annual Meeting Abstract April 2009

Quantification of Changes in the Ocular Barrier Function in Eyes With Retinal Detachment by Laser Flare Cell Meter

S. Schroeder; A. Caramoy; P. Muether; M. Abdel-Salam; M. Diestelhorst; B. Kirchhof; S. Fauser

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3162.

ARVO Annual Meeting Abstract April 2009

Effect of Rapamycin on Postoperative Fibrosis After Filtration Surgery in a Rabbit Model

M. M. Hermann; B. Schröter; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3910.

ARVO Annual Meeting Abstract May 2008

Electronic Compliance Monitoring in Glaucoma Patients Used to Topical Therapy

M. M. Hermann; A. M. Bron; C. P. Creuzot-Garcher; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1582.

ARVO Annual Meeting Abstract May 2008

Optic Nerve Head Characteristics Using Cofocal Laser Scanning Tomography in Glaucoma Patients

M. Diestelhorst; P. Enders; M. M. Hermann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3644.

ARVO Annual Meeting Abstract May 2007

Compliance With Brimonidine Therapy in Patients Aware of Individual Electronic Compliance Monitoring

M. M. Hermann; D. Papaconstantinou; G. Georgopoulos; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5576.

ARVO Annual Meeting Abstract May 2007

Monitoring Individual Compliance in Glaucoma Patients Used to Topical Therapy

A. M. Bron; M. M. Hermann, Jr.; C. Creuzot-Garcher; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5580.

ARVO Annual Meeting Abstract May 2007

Comparative Ocular Pharmacokinetics of Fluorescein Following Application as Lyophilisate and Conventional Eye Drops

M. Diestelhorst; o. Doroshyenko; A. Lux; K. Abduljalil; A. Steinfeld; S. Dinslage; R. Sueverkruep; U. Fuhr

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5793.

ARVO Annual Meeting Abstract May 2006

Fast Precise Freeze Drying of Hyaluronic Acid / Dextran Ophthalmic Lyophilisate Carrier Systems (OLCS)

R.J. Suverkrup; O. Krasichkova; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5130.

ARVO Annual Meeting Abstract May 2006

Monitoring Individual Adherence With Topical Therapy After Glaucoma Surgery

C. Ustundag; M.M. Hermann; M. Diestelhorst

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5493.

1 2

Next 20 Results »

Advertisement